APPLICATIONS PUBLISHED 10 AUGUST 2005

Topical parasiticide formulations and methods of treatment
Schering-Plough 1560572*

Therapeutic agents and corresponding treatments
Medisyn Technologies 1560573*

Antileishmanial dinitroaniline sulphonamides with activity against parasite tubulin
The Ohio State University; National Institutes of Health 1560574*

3,5,3'-triiodothyronine sulphate as thyromimetic agent and pharmaceutical formulations thereof
Bracco 1560575*

Synthesis of oligomeric epicatechin and catechin0derived procyanidines
Mars 1560576*

Pharmaceutical compsns and methods of using taxane derivatives
Bristol-Myers Squibb 1560577*

Use of the distrontium salts of the acid 2-N,N'-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain
Les Laboratoires Servier 1560578*

Cholesterol absorption inhibitors for the treatment of autoimmune disorders
Schering 1560579*

Sulphonamides, sulphamates and salphamides as gamma-secretase inhibitors
Merck Sharp & Dohme 1560580*

Oromucosal formulation and process for preparing the same
Oy Juvantia Pharma 1560581*

Azaindole derivatives as inhibitors of P38 kinase
SCIOS 1560582*

Histone deacetylase inhibitors for the treatment of ocular neovascular or edematous disorders and diseases
Kimko, Peter 1560583*

FAB 1 inhibitors
Affinium Pharmaceuticals 1560584*

The use of an anti-allergy agent and a steroid to treat allergic rhinitis
Alcon 1560586*

Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
Astion Dermatology 1560589*

Synthetic complementary peptides and ophthalmologic uses thereof
Fornix BioSciences 1560590*

Compsns containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
Procyte 1560591*

Treatment of hypersensitivity conditions
The University of Queensland 1560592*

Novel compsn and methods for the treatment of immune related diseases
Genentech 1560593*

Fully human antibody FAB fragments with human interferon-gamma neutralising activity
Amgen 1560595*

Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics
Immunomedics 1560596*

Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
Pharmacia 1560597*

Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity
Les Laboratories Servier; Centre National de la Recherche Scientifique 1560598*

Prodrugs built a multiple self-elimination-release spacers
Syntarga 1560599*

Method for the selective and quantitative functionalisation of immunoglobulin FAB fragments, conjugate compounds obtained with the same and compsns thereof
Bracco Imaging 1560600*

Stabilisation of radiopharmaceuticals labelled with 18-F
Ion Beam Applications; Kiselev, Maxim; Tadino, Vincent 1560601*

Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compsns thereof
Bracco Imaging 1560602*

Method for measuring pancreatic metabolism
Infai Institut fuer Biomedizinische Analytik und NMR-Imaging 1560603*

Bifunctional phenyliso(thio)-cyanates; method and intermediate products for the production thereof
BASF; Hamprecht, Gerhard; Puhl, Michael; Reinhard, Robert; Seitz, Werner 1560810*

Pharmaceutical compsns as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
Abbott Laboratories 1560811*

Aminocyclohexyl ether compounds and uses thereof
Cardiome Pharma 1560812*

Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
NeuroSearch 1560813*

Process for making risperidone and intermediates therefor
Synthon 1560814*

Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
Aventis Pharma Deutschland 1560815*

Quinazoline derivatives
F Hoffmann-La Roche 1560816*

Methods and compsns of novel triazine compounds
Reddy US Therapeutics 1560817*

Non-peptide GNRH agents, pharmaceutical compsns and methods for their use
Pfizer 1560819*

Cannabinoid crystalline derivatives and process of cannabinoid purification
Mallinckrodt 1560819*

Antibacterial agents
SmithKline Beecham 1560821*

4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for GABAA receptors
Neurogen 1560822*

4-substituted 1-aminocyclphexane derivatives for utilisation as ORL-1 receptor and MU-opiate receptor ligands
Gruenenthal 1560823*

Compounds useful as inhibitors of JAK and other protein kinases
Vertex Pharmaceuticals 1560824*

Novel 2,3-dihydro-4(1H)-pyridinone derivatives, method for production thereof and pharmaceutical compsns comprising the same
Les Laboratoires Servier 1560825*

Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
Les Laboratoires Servier 1560826*

Anti-infective agents
Abbott Laboratories 1560827*

Imidazoquinoline derivatives as adenosine A3 receptor ligands
Sanofi-Aventis 1560828*

Pyrimido compounds having antiproliferative activity (II)
F Hoffmann-La Roche 1560829*

Derivatives of [6,7-dihydro-5H-imidazo [1,2-A] imidazole-3-sulphonylamino]-propionamide and their use as inhibitors upon the interaction of CAMS and leukointegrins
Boehringer Ingelheim Pharmaceuticals 1560830*

Novel amino-substituted dihydropyrimido [4,5-D] pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
F Hoffmann-La Roche 1560831*

Pyrimido 4,5-D pyrimidine derivatives with anticancer activity
F Hoffmann-La Roche 1560832*

Preparation of codeine from morphine
Mallinckrodt International 1560833*